Nunzia Pharmaceutical Company

Nunzia Pharmaceutical Company

NUNZ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$43.45K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nunzia Pharmaceutical CompanyNunzia Pharmaceutical Company0-50697%--0.7
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$43,451.00
Enterprise Value$153,118.00
Earnings per Share$-0.26
Beta-3.06
Outstanding Shares434,436,861

Return

Return on Equity50697.31%ROE
Return on Assets-274205.18%
Return on Invested Capital50686.94%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0
Enterprise Value to Net Income-1
Total Debt to Enterprise0.91
Debt to Equity-0.73Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nunzia Pharmaceutical Company

4 employees
CEO: Sara Gonzales

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorder...